218772-96-4

Basic information

• Product Name: (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE
• Synonyms: (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE;2-(4-Oxopiperidin-1-yl)acetic acid
• CAS NO: 218772-96-4
• Molecular Formula: C₇H₁₁NO₃
• Molecular Weight: 193.63
• Mol File: 218772-96-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE(218772-96-4)
• EPA Substance Registry System: (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE(218772-96-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 218772-96-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE is used as an analgesic and anti-inflammatory agent for its potential to alleviate pain and reduce inflammation. Its chemical structure allows it to interact with biological targets, providing therapeutic benefits in various conditions.
Used in Neurological Disorders Treatment:
(4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE is used as a potential treatment for neurological disorders due to its ability to modulate specific pathways and receptors involved in these conditions. Its unique properties may contribute to the development of new therapies for patients suffering from such disorders.
Used in Psychiatric Conditions Management:
(4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE is used as a potential agent for managing psychiatric conditions, given its potential to influence neurotransmitter systems and other biological mechanisms related to mental health. Its application in this field is still under investigation, but it shows promise for further development.
Research on (4-OXO-PIPERIDIN-1-YL)-ACETIC ACID HYDROCHLORIDE is ongoing, and it shows promise for further development in the pharmaceutical industry, as its diverse applications and potential therapeutic effects are explored.

Upstream product

• 41979-39-9 4-piperidone hydrochloride 
• 79-11-8 chloroacetic acid 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 40064-34-4 4-piperidone monohydrochloride monohydrate 

Downstream Products

• 56187-37-2 2-(3,5-dichloro-4-oxopyridine-1(4H)-yl)acetic acid 

Relevant articles and documents

Preparation method of 3,5-dihalogenated-4-pyridone-1-acetic acid

The invention provides a preparation method of 3, 5-dihalogenated-4-pyridone-1-acetic acid, and particularly relates to a preparation method of 3,5-dichloro-4-pyridone-1-acetic acid. The method comprises the following steps: performing a substitution reaction on piperidine-4-ketone hydrochloride (II) with chloroacetic acid in the presence of a proper solvent and an acid-binding agent to obtain 4-piperidone-1-acetic acid (III), carrying out a halogenation reaction on the 4-piperidone-1-acetic acid (III) and a halogenation reagent to obtain 3,3,5,5-tetrahalogenated-4-piperidone-1-acetic acid (IV), carrying out an elimination reaction in the presence of an alkali to remove hydrogen halide, and performing acidification with hydrochloric acid to obtain the 3,5-dihalo-4-pyridinone-1-acetic acid.The method has the advantages of cheap and easily available raw materials, low cost, simple operation, easy realization, less wastewater generation amount, environmental protection, high reaction selectivity, high product yield and purity, and suitableness for industrial production.

Pleuromutilin derivatives as antimicrobials

The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.